Patent Yard Sign in
Canadian application, no grantCanada

Methods and kits for treating and diagnosing leiomyomas

CA 2284039 A1 · Owner: Ortho-Mcneil Pharmaceutical, Inc. · Inventors: Palmer, Stephen S.; Nowak, Romona

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention provides methods of treating a subject suffering from a leiomyoma which comprise administering to the subject a therapeutically effective amount of an agent, or alternatively a plurality of agents which , inhibit specific metalloproteinases. This invention further provides diagnostic methods of determining whether a tumor in a subject is a leiomyoma. This invention further provides pharmaceutical compositions and kits for practicing the instant methods. Finally this invention provides a method of , determining whether an agent specifically inhibits certain metalloproteinases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 18, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 18, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 18, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 18, 1998
GrantedNo grant recorded
Term endedMarch 18, 2018
Patent numberCA 2284039 A1
Classification (IPC)A61K38/57 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedMarch 18, 1998Term endedMarch 18, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.